Efficacy comparison of Allevyn Gentle Border and conventional dressing in rotator cuff repair
| ISRCTN | ISRCTN97372145 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN97372145 |
| Secondary identifying numbers | National Natural Science Foundation of China grant number: 82072514, Science and Technology Department of Sichuan Province grant number: 2022JDKP0091 |
- Submission date
- 30/04/2024
- Registration date
- 01/05/2024
- Last edited
- 17/01/2025
- Recruitment status
- No longer recruiting
- Overall study status
- Ongoing
- Condition category
- Injury, Occupational Diseases, Poisoning
Plain English summary of protocol
Background and study aims
Wound dressings play an essential role in the healing process by providing a physical barrier between the wound and the external environment, thereby preventing further injury or infection by opportunistic microorganisms from occurring. The optimal wound dressing should be capable of removing multifaceted obstacles in the healing process of skin wounds. Both Allevyn Gentle Border and Cosmopor E Steri1 dressings are applicable for surgical wound management. Although a single sheet of Cosmopor E Steril may seem relatively inexpensive, its limited reusability and frequent need for replacement increase the overall cost of wound management. On the other hand, while a single sheet of Allevyn Gentle Border may seem relatively expensive, its reusability for up to 7 days after removal and waterproof properties are ideal features for patient’s self-management of wounds. Therefore, this study will evaluate and compare the non-inferiority of Allevyn Gentle Border compared to Cosmopor E Steri1 in wound management aiming to expand the range of dressing options for managing surgical wounds from rotator cuff repair.
Who can participate?
Patients aged 18 to 80 years old with rotator cuff repair
What does the study involve?
The dressings (Allevyn Gentle Border and Cosmopor E Steri1) will be placed over the surgical wound during the first dressing change post-operation. Every patient will be provided with 3 follow-up visits in the outpatient clinic 1, 2 and 4 weeks after surgery to remove the dressing and evaluate the wound condition.
What are the possible benefits and risks of participating?
Participating patients may reduce dressing change frequency and related costs, enhance postoperative life satisfaction or may not benefit directly from this study. The study will generate essential information, which could be of benefit to others in the future.
Possible adverse events in this study may include but are not limited to peri-wound skin irritation, blistering, redness, stinging or burning while wearing the dressing, pain and itching under the dressing, dressing intolerance, skin damage from medical adhesive and allergic dermatitis. Every possible effort will be taken to minimise the potential of these risks occurring.
Where is the study run from?
West China Hospital, Sichuan University (China)
When is the study starting and how long is it expected to run for?
March 2024 to August 2025
Who is funding the study?
1. National Natural Science Foundation of China
2. Science and Technology Department of Sichuan Province
Who is the main contact?
Prof Peng-cheng Li, hx120120@gmail.com
Contact information
Scientific, Principal Investigator
No.37 Guoxue Alley, Wuhou District
Chengdu, Sichuan Province
610041
China
| Phone | +86 18980601911 |
|---|---|
| 16699411@qq.com |
Public
No.37 Guoxue Alley, Wuhou District
Chengdu, Sichuan Province
610041
China
| Phone | +86 17857314966 |
|---|---|
| 624513481@qq.com |
Study information
| Study design | Prospective randomized parallel-controlled single-center open-label trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised parallel trial |
| Study setting(s) | Hospital, Medical and other records |
| Study type | Quality of life, Safety, Efficacy |
| Participant information sheet | Not available in web format, please use contact details to request a paticpant information sheet |
| Scientific title | Efficacy of Allevyn Gentle Border dressing versus conventional wound dressing in patients with surgical wounds from rotator cuff repair: a randomized controlled non-inferiority trial |
| Study objectives | It is hypothesised that Allevyn Gentle Border dressing will be both feasible and acceptable in wound management with rotator cuff repair. |
| Ethics approval(s) |
Approved 17/04/2024, Ethics Committee on Biomedical Research, West China Hospital of Sichuan University (Room 412~413, Laobajiao, No.37 Guoxue Alley, Wuhou District, Chengdu, Sichuan Province, 610041, China; +86 028-65423237; huaxilunli@163.com), ref: 2024 Review (463) |
| Health condition(s) or problem(s) studied | To expand the range of dressing options for managing surgical wounds from rotator cuff repair |
| Intervention | This is a non-inferiority trial and cost-benefit analysis of silicone adhesive foam dressing for wound management after rotator cuff suture repair. The sample size will be 68 patients who will be randomly assigned 1:1 to an experimental group (34 patients) that will use either the study dressing (Allevyn Gentle Border) or a control dressing (34 patients) of conventional adhesive dressing (Cosmopor E Steri1). The randomization method employed is simple randomization. Specifically, participants will be randomly assigned to the experimental or control group in a 1:1 ratio according to random numbers generated by SPSS version 25.0 (SPSS Inc., Chicago, Illinois, USA). The dressings will be placed during the first dressing change post-operation. Every patient will be provided with 3 follow-up visits in the outpatient at 1 week, 2 weeks, and 4 weeks after surgery, remove the dressing and evaluate the wound condition. |
| Intervention type | Device |
| Pharmaceutical study type(s) | Not Applicable |
| Phase | Phase 0 |
| Drug / device / biological / vaccine name(s) | Allevyn Gentle Border dressing, Cosmopor E Steri1 dressing |
| Primary outcome measure | The following primary outcome measures will be assessed using data collected from study records at 1, 2 and 4 weeks after surgery: 1. Incidence rate of wound complications 2. The cost-effectiveness of wound care, analyzed using the cost-effectiveness ratio (CER) and incremental cost-effectiveness ratio (ICER). The total direct costs related to surgical wound care will include registration fees, dressing change costs, dressing costs and the cost of management of complications |
| Secondary outcome measures | The following secondary outcome measures will be assessed, unless stated, using data collected from study records at 1, 2 and 4 weeks after surgery: 1. Wound healing rate 2. Healing time 3. Dressing wear time 4. Number of dressing changes 5. Clinician's evaluation of dressing performance characteristics measured using a Likert 4-point scoring method 6. Patient's evaluation of the dressing measured using a Likert 4-point scoring method |
| Overall study start date | 01/03/2024 |
| Completion date | 31/08/2025 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Mixed |
| Lower age limit | 18 Years |
| Upper age limit | 80 Years |
| Sex | Both |
| Target number of participants | 68 |
| Key inclusion criteria | 1. Age between 18 and 80 years 2. Undergoing initial rotator cuff repair 3. Surgical procedures will be performed by the same surgeon using the same surgical technique and suture materials 4. Good patient compliance and regular follow-ups are essential 5. Voluntary participation in the study with signed informed consent |
| Key exclusion criteria | 1. Patients with conditions that may affect wound healing, including hypertension, diabetes, hypoproteinemia, malnutrition (defined as body mass index or BMI < 18.5 kg/m2), severe obesity (defined as BMI > 28 kg/m2), rheumatoid disease, tumor, connective tissue disease, hemophilia, limb vascular disease, psoriasis, radiation injury, gangrene, genetic diseases, anemia, gout, or other diseases that may affect wound healing 2. Long-term use of immunosuppressive agents, glucocorticoids, biological agents, anticoagulants, antiplatelet drugs, or no standardized adjustment and withdrawal pre-surgery 3. Long-term history of smoking or alcohol consumption 4. Preoperative history of surgery or infection at the surgical site 5. Scars, skin lesions, or rashes at the surgical site pre-surgery 6. Recent history (within 1 month) of invasive procedures, such as acupuncture, small needle knife, or drug injection at the surgical site 7. Psoriasis, eczema, dermatitis or other skin diseases 8. Allergic to any dressing components |
| Date of first enrolment | 01/12/2024 |
| Date of final enrolment | 01/03/2025 |
Locations
Countries of recruitment
- China
Study participating centre
Chengdu, Sichuan Province
610041
China
Sponsor information
Hospital/treatment centre
No.37 Guoxue Alley, Wuhou District
Chengdu, Sichuan Province
610041
China
| Phone | +86 86298033 |
|---|---|
| Hx120120@gmail.com | |
| Website | http://www.wchscu.cn/index.html |
"ROR" |
https://ror.org/007mrxy13 |
Funders
Funder type
Government
Government organisation / National government
- Alternative name(s)
- Chinese National Science Foundation, Natural Science Foundation of China, National Science Foundation of China, NNSF of China, NSF of China, 国家自然科学基金委员会, National Nature Science Foundation of China, Guójiā Zìrán Kēxué Jījīn Wěiyuánhuì, NSFC, NNSF, NNSFC
- Location
- China
Government organisation / Local government
- Alternative name(s)
- Sichuan Provincial Department of Science and Technology, Department of Science and Technology of Sichuan Province, Science & Technology Department of Sichuan Province, 四川省科学技术厅, SPDST
- Location
- China
Results and Publications
| Intention to publish date | 31/10/2025 |
|---|---|
| Individual participant data (IPD) Intention to share | Yes |
| IPD sharing plan summary | Available on request |
| Publication and dissemination plan | Planned publication in a peer-reviewed journal |
| IPD sharing plan | The datasets generated during and/or analysed during the current study will be available upon request from the corresponding author, Prof Peng-cheng Li, 16699411@qq.com. |
Editorial Notes
17/01/2025: The overall study end date was changed from 31/05/2025 to 31/08/2025.
11/11/2024: The following changes were made to the study record:
1. The recruitment start date was changed from 01/06/2024 to 01/12/2024.
2. The recruitment end date was changed from 01/09/2024 to 01/03/2025.
3. The overall study end date was changed from 31/10/2024 to 31/05/2025.
4. The public title was changed from 'Allevyn Gentle Border dressing versus control dressing in patients with rotator cuff repair' to 'Efficacy comparison of Allevyn Gentle Border and conventional dressing in rotator cuff repair'.
5. The scientific title was changed from 'A randomized controlled non-inferiority trial comparing the efficacy of Allevyn Gentle Border dressing to a conventional wound dressing in patients with surgical wounds from rotator cuff repair' to 'Efficacy of Allevyn Gentle Border dressing versus conventional wound dressing in patients with surgical wounds from rotator cuff repair: a randomized controlled non-inferiority trial.'
30/04/2024: Study's existence confirmed by the Biomedical Ethics Review Committee of West China Hospital of Sichuan University.
